NCT04174898

MSC Infusion for Anti-aging and Regenerative Therapy

Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Landmark Medical Centre Sdn Bhd · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To evaluate the safety and efficacy of human Mesenchymal Stem Cell (hMSC) infusion therapy, in preserving general wellness and ameliorating or reversing the effects of aging in our study population

Detailed description

100million human mesenchymal stem cells will be infused into study subjects. They will be followed up for both objective and subjective measures of 'anti-aging'. Biochemical markers such as male and female hormones and other parameters of well being will be measured. A questionnaire will also be filled pre and post infusion to ascertain one's well-being (Adapted from SF-36). Source of MSCs - Autologous (Adipose tissue) or Allogenic (Adipose tissue or umbilical cord) MSC production and storage will be performed in a GMP certified laboratory setting.

Conditions

• Aging Well
• Regenerative Medicine

Interventions

Type	Name	Description
BIOLOGICAL	human Mesenchymal Stem Cell (MSC) infusion therapy	Subjects will be infused with 100million human MSCs

Timeline

• Start date: 2020-04-15
• Primary completion: 2021-04-14
• Completion: 2022-04-14
• First posted: 2019-11-22
• Last updated: 2019-11-22

Locations

1 site across 1 country: Malaysia